Summit Partners
VC Fund
Boston, United States
Summit Partners is an investment firm that is currently investing in to growth equity, fixed income, and public equity opportunities. Summit has invested in more than 460 companies in technology, healthcare, life sciences, and other growth industries.Summit Partners enhances the value of these companies through infrastructure development,executive and board recruiting, and strategic and operational advice. The firm also brings extensive experience in helping companies navigate the complex process of public offerings or strategic sales and mergers.
- Total investments:
- 235
- Last investment:
- Lead investor:
- 67%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Summit Partners invests in
Stages Summit Partners invests in
Countries Summit Partners invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series B
- $15M–$150M
- Private Equity
- $30M–$250M
Investment Focus
Industry
- Software 72 (31%)
- Information Technology 26 (11%)
- Health Care 25 (11%)
- SaaS 24 (10%)
- Analytics 20 (9%)
Stage
- Private Equity 84 (36%)
- Series B 26 (11%)
- Funding Round 25 (11%)
- Series C 21 (9%)
- Series A 17 (7%)
Country
- United States 116 (49%)
- Germany 9 (4%)
- Canada 5 (2%)
- France 5 (2%)
- United Kingdom 5 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Daniel Kim
Principal
|
Principal | Total investments: 2 | Find email | |
Ryan McDonald
Principal - Healthcare & Life Sciences
|
Principal - Healthcare & Life Sciences | Total investments: 3 | Find email | |
Andrew R. McCarthy
Principal
|
Principal | Total investments: 0 | Find email | |
Antony C. Clavel
Managing Director
|
Managing Director | Total investments: 6 | Find email | |
Bob Geiman
Entrepreneur In Residence
|
Entrepreneur In Residence | Total investments: 2 | Find email | |
| See all 41 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Keyfactor
|
Keyfactor, formerly Certified Security Solutions (CSS), is a leading provider of secure digital identity management solutions that enables organizations to confirm authenticity, and ensure the right things are interacting in the right ways in our connected world.From an enterprise managing millions of devices and applications that affect people’slives every day, to a manufacturer aiming to ensure its product will function safely throughout its life cycle, Keyfactor empowers global enterprises with the freedom to master every digital identity. Its clients are the most innovative brands in the industries where trust and reliability matter most. | $1B / Private Equity / Jul 06, 2026 | |
|
Keyfactor
|
Keyfactor, formerly Certified Security Solutions (CSS), is a leading provider of secure digital identity management solutions that enables organizations to confirm authenticity, and ensure the right things are interacting in the right ways in our connected world.From an enterprise managing millions of devices and applications that affect people’slives every day, to a manufacturer aiming to ensure its product will function safely throughout its life cycle, Keyfactor empowers global enterprises with the freedom to master every digital identity. Its clients are the most innovative brands in the industries where trust and reliability matter most. | $1B / Private Equity / Jul 06, 2026 | |
Quantifind
|
Quantifind provides AI solutions for anti-money laundering and fraud detection that uniquely discover risk by combining internal financial institution data with public domain data. Founded in 2008 by two atomic physics Ph.D.s, the company has offices in Silicon Valley, New York, and Washington, DC. For more information, please visithttp://www.quantifind.com. | $200M / Venture - Series Unknown / Jun 26, 2026 | |
Runpod
|
Runpod is a cloud platform specifically designed for AI, providing GPU infrastructure that simplifies the building and deployment of models in a matter of seconds. It offers cost-effective GPU cloud computing services tailored for training, deploying, and scaling AI models efficiently. | $100M / Series A / Jun 24, 2026 | |
Hyperlight
|
HyperLight provides thin-film lithium niobate photonic integrated circuit solutions. They deliver groundbreaking electro-optic and nonlinear optical solutions with scalable manufacturing processes. They work closely with their customers from conceptualization, design, prototyping, and transfer to volume production. | $80M / Series C / Jun 18, 2026 | |
Stay22
|
Over half the total spend on hotels and short-term rentals – $295B each year – comes from event accommodations for conferences, concerts, festivals, and sporting events. This is an incredibly underserved market. Event organizers typically view attendee accommodations as a non-revenue-producing activity and spend countless hours reserving blocks ofrooms for $0 in return. Stay22 turns this into a HUGE new source of revenue for the event organizers who partner with us | $122M / Private Equity / Feb 26, 2026 | |
|
Stay22
|
Over half the total spend on hotels and short-term rentals – $295B each year – comes from event accommodations for conferences, concerts, festivals, and sporting events. This is an incredibly underserved market. Event organizers typically view attendee accommodations as a non-revenue-producing activity and spend countless hours reserving blocks ofrooms for $0 in return. Stay22 turns this into a HUGE new source of revenue for the event organizers who partner with us | $122M / Private Equity / Feb 26, 2026 | |
Dreampath Diagnostics
|
Dreampath Diagnostics develops solutions for pathology labs. Their new and innovative solutions help with automation, workflow, and digital traceability in pathology labs. They provide patients access to faster and more reliable diagnostics by enabling pathologists with rapid, safe, and accurate access to paraffin blocks and other digitaltraceability solutions. | Private Equity / Jul 14, 2025 | |
|
Dreampath Diagnostics
|
Dreampath Diagnostics develops solutions for pathology labs. Their new and innovative solutions help with automation, workflow, and digital traceability in pathology labs. They provide patients access to faster and more reliable diagnostics by enabling pathologists with rapid, safe, and accurate access to paraffin blocks and other digitaltraceability solutions. | Private Equity / Jul 14, 2025 | |
Quorso
|
Quorso simplifies your data into 3 top-priority daily actions (we call them ‘Missions’) for every store, guaranteed to engage teams, increase Sales and drive KPIs. Then helps teams to launch their Missions, measures the impact and scales the ones that work. | Venture - Series Unknown / Jul 07, 2025 | |
| See all 235 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Summit Partners invest in?
Summit Partners invests primarily in Software, Information Technology and Health Care startups, most often at Private Equity and Series B stage. Most of the 235 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Summit Partners's check size?
Summit Partners typically joins rounds of $15M–$150M at Series B and $30M–$250M at Private Equity. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Summit Partners participates in.
How do I contact Summit Partners?
Public channels for Summit Partners include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Summit Partners?
The team at Summit Partners includes Daniel Kim (Principal), Ryan McDonald (Principal - Healthcare & Life Sciences) and Andrew R. McCarthy (Principal), among 41 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
